[1]
S. Shiekh and I. Aslam, “LOW-DOSE ASPIRIN DID NOT REDUCE DEMENTIA RISK IN TYPE 2 DIABETES ADULTS”, CF, vol. 1, no. 21, pp. 135–139, Jan. 2023.